Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Colm Morrissey

Showing results (41-50 of 172) with videos related to

Pageof 18
Sort By:
Oncogene|October 3, 2020
De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-MycOh-Joon Kwon, Li Zhang, Deyong Jia, et al.
Anti-Cancer Drugs|February 5, 2010
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cellsColm Morrissey, Byron Gallis, Jeffrey W Solazzi, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
Anticancer Research|July 3, 2017
Inhibition of ERG Activity in Patient-derived Prostate Cancer Xenografts by YK-4-279Brian Winters, Lisha Brown, Ilsa Coleman, et al.
Plos One|November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastasesXiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander Frank, Ruth Dumpit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate CancerIlsa M Coleman, Navonil DeSarkar, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cellsHaiyen E Zhau, Hui He, Christopher Y Wang, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
The Prostate|November 20, 2013
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastasesGillian O'Hurley, Maria Prencipe, Dara Lundon, et al.
Pageof 18

Showing results (41-50 of 172) with videos related to

Sort By:
Pageof 18
Oncogene|October 3, 2020
De novo induction of lineage plasticity from human prostate luminal epithelial cells by activated AKT1 and c-MycOh-Joon Kwon, Li Zhang, Deyong Jia, et al.
Anti-Cancer Drugs|February 5, 2010
Effect of artemisinin derivatives on apoptosis and cell cycle in prostate cancer cellsColm Morrissey, Byron Gallis, Jeffrey W Solazzi, et al.
Asian Journal of Urology|December 22, 2017
Mismatch repair enzyme expression in primary and castrate resistant prostate cancerBelinda Nghiem, Xiaotun Zhang, Hung-Ming Lam, et al.
Anticancer Research|July 3, 2017
Inhibition of ERG Activity in Patient-derived Prostate Cancer Xenografts by YK-4-279Brian Winters, Lisha Brown, Ilsa Coleman, et al.
Plos One|November 25, 2011
Androgen receptor variants occur frequently in castration resistant prostate cancer metastasesXiaotun Zhang, Colm Morrissey, Shihua Sun, et al.
Biorxiv : the Preprint Server for Biology|September 18, 2025
Genotoxic antibody-drug conjugates combined with Bcl-xL inhibitors enhance therapeutic efficacy in metastatic castration-resistant prostate cancerGalina Semenova, Sander Frank, Ruth Dumpit, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 13, 2022
Therapeutic Implications for Intrinsic Phenotype Classification of Metastatic Castration-Resistant Prostate CancerIlsa M Coleman, Navonil DeSarkar, Colm Morrissey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 1, 2011
Human prostate cancer harbors the stem cell properties of bone marrow mesenchymal stem cellsHaiyen E Zhau, Hui He, Christopher Y Wang, et al.
The Prostate|August 8, 2015
Relationship between serum response factor and androgen receptor in prostate cancerMaria Prencipe, Amanda O'Neill, Gillian O'Hurley, et al.
The Prostate|November 20, 2013
The analysis of serum response factor expression in bone and soft tissue prostate cancer metastasesGillian O'Hurley, Maria Prencipe, Dara Lundon, et al.
Pageof 18